Progenesis is a San Diego-based company founded in 2015 that develops and offers non-invasive genetic tests for patients on their family planning journey. We offer a variety of services that can be customized to meet the needs of every patient we serve. The Progenesis team is a motivated group of genetic specialists, researchers, laboratory professionals, and analysts who are passionate about improving our patients' lives. As pioneers in genetic screening technologies, our scientists are constantly pursuing research initiatives to advance our services and expand our understanding of human genetics.
Address: 4150 Regents Park Row Suite 245 La Jolla, CA 92037
Novelvi® can be performed as soon as 10 weeks into pregnancy to evaluate the health of the developing fetus. The test screens for chromosomal abnormalities (aneuploidy) which can be associated with severe syndromes. Our Novelvi® panels use the latest sequencing technology to deliver extremely accurate results. Learn more about our two panels below.
Screens for the 3 most common aneuploidies:
Trisomy 21 (Down syndrome)
Intellectual disability, distinct facial features, and muscle weakness during infancy.
Trisomy 18 (Edwards syndrome)
Intrauterine growth retardation, small abnormally shaped head, and other birth defects.
Trisomy 13 (Patau syndrome)
Severe intellectual disability and a variety of physical defects affecting many organs.
Screens all 24 chromosomes for aneuploidy plus clinically relevant microdeletions. These include: